Brooks O'Neil
Stock Analyst at Lake Street
(0.46)
# 4,360
Out of 4,988 analysts
319
Total ratings
39.8%
Success rate
-2.6%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Reiterated: Buy | $12 → $18 | $3.22 | n/a | 9 | Jul 10, 2025 | |
| TNDM Tandem Diabetes Care | Reiterated: Buy | $75 | $16.87 | n/a | 37 | May 20, 2025 | |
| PIII P3 Health Partners | Reiterated: Buy | $20 | $7.67 | n/a | 13 | May 16, 2025 | |
| ELMD Electromed | Reiterated: Buy | $36 | $26.53 | n/a | 9 | May 14, 2025 | |
| ASTH Astrana Health | Reiterated: Buy | $70 | $34.36 | n/a | 14 | May 9, 2025 | |
| ORGO Organogenesis Holdings | Reiterated: Buy | $5 | $1.42 | n/a | 5 | May 9, 2025 | |
| RCEL AVITA Medical | Reiterated: Buy | $14 | $11.02 | n/a | 29 | May 9, 2025 | |
| INFU InfuSystem Holdings | Reiterated: Buy | $13 | $12.85 | n/a | 15 | May 8, 2025 | |
| BBNX Beta Bionics | Reiterated: Buy | $30 | $21.89 | n/a | 3 | May 7, 2025 | |
| LFVN LifeVantage | Reiterated: Buy | $30 | $6.35 | n/a | 6 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $8.91 | n/a | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $10.18 | n/a | 36 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.2336 | n/a | 24 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.77 | n/a | 8 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $10 | $0.015 | n/a | 16 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $55 | $33.08 | n/a | 23 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $78.87 | n/a | 12 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $15 | $8.44 | n/a | 16 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $4 | $0.0001 | n/a | 3 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $25 | $0.897 | n/a | 3 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $200 | $0.0001 | n/a | 3 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $45 | $24.30 | n/a | 10 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $2.20 | n/a | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.5856 | n/a | 1 | Apr 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $0.34 | $4.55 | n/a | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $6.85 | n/a | 1 | Aug 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $55.50 | n/a | 2 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $27 | $23.35 | n/a | 2 | May 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $5.50 | n/a | 1 | May 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $40 | $82.47 | n/a | 2 | Dec 12, 2013 |
LifeMD
Jul 10, 2025
Reiterated: Buy
Price Target: $12 → $18
Current: $3.22
Upside: n/a
Tandem Diabetes Care
May 20, 2025
Reiterated: Buy
Price Target: $75
Current: $16.87
Upside: n/a
P3 Health Partners
May 16, 2025
Reiterated: Buy
Price Target: $20
Current: $7.67
Upside: n/a
Electromed
May 14, 2025
Reiterated: Buy
Price Target: $36
Current: $26.53
Upside: n/a
Astrana Health
May 9, 2025
Reiterated: Buy
Price Target: $70
Current: $34.36
Upside: n/a
Organogenesis Holdings
May 9, 2025
Reiterated: Buy
Price Target: $5
Current: $1.42
Upside: n/a
AVITA Medical
May 9, 2025
Reiterated: Buy
Price Target: $14
Current: $11.02
Upside: n/a
InfuSystem Holdings
May 8, 2025
Reiterated: Buy
Price Target: $13
Current: $12.85
Upside: n/a
Beta Bionics
May 7, 2025
Reiterated: Buy
Price Target: $30
Current: $21.89
Upside: n/a
LifeVantage
May 7, 2025
Reiterated: Buy
Price Target: $30
Current: $6.35
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $15
Current: $8.91
Upside: n/a
May 2, 2025
Reiterated: Buy
Price Target: $18
Current: $10.18
Upside: n/a
May 1, 2025
Reiterated: Buy
Price Target: $6
Current: $0.2336
Upside: n/a
May 1, 2025
Reiterated: Buy
Price Target: $12
Current: $4.77
Upside: n/a
Jan 13, 2025
Rated: Buy
Price Target: $30 → $10
Current: $0.015
Upside: n/a
Nov 14, 2024
Rated: Buy
Price Target: $55
Current: $33.08
Upside: n/a
May 3, 2024
Reiterated: Buy
Price Target: $75
Current: $78.87
Upside: n/a
Mar 8, 2024
Rated: Buy
Price Target: $30 → $15
Current: $8.44
Upside: n/a
Feb 9, 2024
Reiterated: Buy
Price Target: $20 → $4
Current: $0.0001
Upside: n/a
Mar 1, 2023
Reiterated: Buy
Price Target: $3 → $25
Current: $0.897
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $8 → $200
Current: $0.0001
Upside: n/a
Jul 28, 2022
Reiterated: Buy
Price Target: $35 → $45
Current: $24.30
Upside: n/a
Apr 8, 2022
Initiated Coverage: Buy
Price Target: $11
Current: $2.20
Upside: n/a
Apr 9, 2021
Initiated Coverage: Buy
Price Target: $20
Current: $0.5856
Upside: n/a
Sep 15, 2020
Initiated Coverage: Buy
Price Target: $0.34
Current: $4.55
Upside: n/a
Aug 17, 2020
Reiterated: Buy
Price Target: $14
Current: $6.85
Upside: n/a
Jul 28, 2020
Reiterated: Buy
Price Target: $15
Current: $55.50
Upside: n/a
May 1, 2020
Reiterated: Buy
Price Target: $22 → $27
Current: $23.35
Upside: n/a
May 20, 2019
Initiated Coverage: Buy
Price Target: $7
Current: $5.50
Upside: n/a
Dec 12, 2013
Reiterated: Buy
Price Target: $35 → $40
Current: $82.47
Upside: n/a